B. Barrow
University of Oxford(GB)Oxford Centre for Diabetes, Endocrinology and Metabolism(GB)
Publications by Year
Research Areas
Pancreatic function and diabetes, Diabetes and associated disorders, Metabolism, Diabetes, and Cancer, Diabetes, Cardiovascular Risks, and Lipoproteins, Blood Pressure and Hypertension Studies
Most-Cited Works
- → Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38(1998)4,820 cited
- Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39(1998)
- Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40(1998)
- → Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM(1997)268 cited
- → Normalization of Insulin Responses to Glucose by Overnight Infusion of Glucagon-Like Peptide 1 (7–36) Amide in Patients With NIDDM(1996)116 cited
- → High prevalence of a missense mutation of the glucokinase gene in gestational diabetic patients due to a founder-effect in a local population(1996)65 cited
- → Clinical Characteristics of Subjects with a Missense Mutation in Glucokinase(1995)56 cited
- → Safety of antipsychotics in people with intellectual disability(2011)55 cited
- → UKPDS 21: Low Prevalence of the Mitochondrial Transfer RNA gene (tRNALeu(UUR)) Mutation at Position 3243bp in UK Caucasian Type 2 Diabetic Patients(1997)51 cited
- → Identification of a Novel β-Cell Glucokinase (GCK) Promoter Mutation (−71G>C) That ModulatesGCKGene Expression Through Loss of Allele-Specific Sp1 Binding Causing Mild Fasting Hyperglycemia in Humans(2009)44 cited